ArticleNephrology (Carlton, Vic.)2025

Allopurinol Versus Febuxostat Use and the Risk of Cardiovascular Disease in People With Chronic Kidney Disease: A New-User Active Comparator Cohort Study.

Reiko Inoue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.